Yasuhiro Asahina

8PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersMolecular medicineLiquid biopsiesEpidemiological methodsGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Jan 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients.

Nobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi

|Sep 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.

Yuta Myojin, Hayato Hikita, Yuki Tahata

|May 27, 2025
Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases.

Fukiko Kawai-Kitahata, Yasuhiro Asahina, Sei Kakinuma

|Mar 07, 2024
Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.

Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa

|Jan 17, 2023
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.

Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki

Pageof 2

Frequent Collaborators

4 joint publications

Nobuharu Tamaki

3 joint publications

Hayato Hikita

2 joint publications

Seiichi Mawatari

2 joint publications

Hidekatsu Kuroda